Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces today the outcome of its Annual General Meeting (“AGM”) which took place on June 29, 2011, in Marseilles, France.
A number of 26,483,176 votes were expressed out of a total of 37,568,383 shares with voting rights, representing a quorum of 70.5%. All resolutions were voted in accordance with the management’s recommendations.
During the AGM, the Board members mandates were renewed and Alta BioPharma Partners II, LP, represented by Ms Ekaterina Smirnyagina, was appointed as a new member of the Supervisory Board.
The AGM was followed by a meeting of the Supervisory Board on the same day, which appointed Mr Gilles Brisson as Chairman and Ms Irina Staatz-Granzer as Vice-Chairman of the Supervisory Board.
| PR in English | 135.36 KB |
| CP en français | 146.43 KB |
| Quorum | 57.54 KB |
| Résultat du scrutin | 256.12 KB |